Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review
Surgical Oncology, 08/09/2012
Evidence Based Medicine
Saxena A et al. – Hepatic resection for Neuroendocrine tumours (NET) hepatic metastases (NETHM) provides symptomatic benefit and is associated with favourable survival outcomes although the majority of patients invariably develop disease progression.



